Meet Proteona at the VIB Next-Generation Protein Analysis and Detection (3rd edition) conference in Ghent, Belgium
Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology
Dr Andreas Schmidt, the Chief Executive Officer of Proteona, will be presenting at the VIB Next-Generation Protein Analysis and Detection (3rd edition) conference, taking place in Ghent, Belgium, from the 2nd to 3rd December 2019. His talk, titled “Managing Tumor heterogeneity: Single Cell ProteoGenomics from research to clinical impact”, is scheduled at 11.05am on the 3rd December. It is part of the plenary session “Single Cell & Single Protein Analysis”.
Join us to explore cutting edge technologies from top scientists and companies, and to learn about how Proteona helps to address tumor heterogeneity with single cell multi-omics analysis.
For media queries, please contact:
Dr Andreas Schmidt
Proteona Pte. Ltd. is a new biomedical company based in Singapore, Germany, and the US that is pioneering the use of DNA barcoded antibodies to provide both proteomic and genomic information from the same single cells. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research’s (A*STAR). The platform is a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles.